Generic placeholder image

Pharmaceutical Nanotechnology

Editor-in-Chief

ISSN (Print): 2211-7385
ISSN (Online): 2211-7393

Research Article

Topical Nanostructured Lipid Carriers of Alpha-mangostin and Resveratrol for Synergistic Antioxidant Activity

Author(s): Wipada Samprasit, Chitralada Vasarach, Praneet Opanasopit, Pornsak Sriamornsak and Benchawan Chamsai*

Volume 10, Issue 3, 2022

Published on: 09 June, 2022

Page: [220 - 231] Pages: 12

DOI: 10.2174/2211738510666220426112508

Price: $65

Abstract

Background: Nanostructured lipid carriers (NLCs) are interesting lipid-based carrier systems for enhancing the penetration of drugs through the skin after topical administration.

Objective: Dual drug-loaded NLCs of alpha-mangostin (M) and resveratrol (R) to enhance antioxidant activity were developed for topical delivery.

Methods: The efficacy of a combination of M and R was evaluated in terms of the antioxidant activity. M and R were loaded into the NLCs using a high shear homogenization and ultrasonication process. The particle size, zeta potential, and physical properties of the NLCs were observed. The M and R loading efficiency, as well as release patterns, were examined using Franz diffusion cells. Moreover, the antioxidant efficacy and in vitro cytotoxicity in the normal human fibroblast (NHF) of the NLCs were evaluated as well.

Results: The results found that the combination of M and R offered synergistic antioxidant activity and was successfully loaded into the NLCs with the size of a nanometer and negative zeta potential. The drugs were loaded in the NLCs as molecular dispersions and slowly released from the NLCs. Interestingly, both drugs maintained their antioxidant activity after being loaded into the NLCs and provided a higher antioxidant activity than those in the single loading of M and R, thus demonstrating that the incorporation of M and R into the NLCs allowed an enhanced antioxidant activity. Moreover, a cytotoxicity study showed that the NLCs were safe and had low cytotoxicity on the NHF cells.

Conclusion: The M and R loaded NLCs were attractive systems for the synergistic antioxidant activity for topical application.

Keywords: Nanostructured lipid carriers, alpha-mangostin, resveratrol, synergy, antioxidant activity, topical application.

Graphical Abstract

[1]
Rizwanullah M, Amin S, Ahmad J. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. J Drug Target 2017; 25(1): 58-74.
[http://dx.doi.org/10.1080/1061186X.2016.1191080] [PMID: 27186665]
[2]
Khatoon K, Rizwanullah M, Amina S, et al. Cilnidipine loaded transfersomes for transdermal application: Formulation optimization, in-vitro and in-vivo study. J Drug Deliv Sci Technol 2019; 54101303
[http://dx.doi.org/10.1016/j.jddst.2019.101303]
[3]
Rizwanullah M, Ahmad MZ, Garg A, Ahmad J. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochim Biophys Acta, Gen Subj 2021; 1865(9)129936
[http://dx.doi.org/10.1016/j.bbagen.2021.129936] [PMID: 34058266]
[4]
Dubey A, Prabhu P, Kamath JV. Nanostructured lipid carriers: A novel topical drug delivery system. Int J Pharm Tech Res 2012; 4: 705-14.
[5]
Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration. J Control Release 2002; 81(3): 225-33.
[http://dx.doi.org/10.1016/S0168-3659(02)00056-1] [PMID: 12044563]
[6]
Baek J, Lee MG. Oxidative stress and antioxidant strategies in dermatology. Redox Rep 2016; 21(4): 164-9.
[http://dx.doi.org/10.1179/1351000215Y.0000000015] [PMID: 26020527]
[7]
Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress. A review Neuroscience 2019; 406: 1-21.
[http://dx.doi.org/10.1016/j.neuroscience.2019.02.020] [PMID: 30825584]
[8]
Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull 2015; 5(3): 305-13.
[http://dx.doi.org/10.15171/apb.2015.043] [PMID: 26504751]
[9]
Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366(1-2): 170-84.
[http://dx.doi.org/10.1016/j.ijpharm.2008.10.003] [PMID: 18992314]
[10]
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004; 24(5A): 2783-840.
[PMID: 15517885]
[11]
Martínez A, Galano A, Vargas R. Free radical scavenger properties of α-mangostin: Thermodynamics and kinetics of HAT and RAF mechanisms. J Phys Chem B 2011; 115(43): 12591-8.
[http://dx.doi.org/10.1021/jp205496u] [PMID: 21936544]
[12]
Duarte A, Martinho A, Luís A, et al. Resveratrol encapsulation with methyl-β-cyclodextrin for antibacterial and antioxidant delivery applications. Lebensm Wiss Technol 2015; 63: 1254-60.
[http://dx.doi.org/10.1016/j.lwt.2015.04.004]
[13]
Juškaitė V, Ramanauskienė K, Briedis V. Testing of resveratrol microemulsion photostability and protective effect against UV induced oxidative stress. Acta Pharm 2017; 67(2): 247-56.
[http://dx.doi.org/10.1515/acph-2017-0018] [PMID: 28590913]
[14]
Samprasit W, Akkaramongkolporn P, Jaewjira S, et al. Design of alpha mangostin-loaded chitosan/alginate controlled-release nanoparticles using genipin as crosslinker. J Drug Deliv Sci Technol 2018; 46: 312-21.
[http://dx.doi.org/10.1016/j.jddst.2018.05.029]
[15]
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
[http://dx.doi.org/10.1016/0065-2571(84)90007-4] [PMID: 6382953]
[16]
Chamsai B, Samprasit W, Opanasopit PP, et al. Types of solid lipids on physical stability of resveratrol-loaded nanostructured lipid carriers. Key Eng Mater 2020; 859: 203-7.
[http://dx.doi.org/10.4028/www.scientific.net/KEM.859.203]
[17]
Arora R, Aggarwal G, Harikumar SL, et al. Nanoemulsion based hydrogel for enhanced transdermal delivery of Ketoprofen. Adv Pharm J 2014; 2014468456
[http://dx.doi.org/10.1155/2014/468456]
[18]
Fachinetti N, Rigon RB, Eloy JO, Sato MR, Dos Santos KC, Chorilli M. Comparative study of glyceryl behenate or polyoxyethylene 40 stearate-based lipid carriers for trans-resveratrol delivery: Development, characterization and evaluation of the in vitro tyrosinase inhibition. AAPS PharmSciTech 2018; 19(3): 1401-9.
[http://dx.doi.org/10.1208/s12249-018-0961-z] [PMID: 29404955]
[19]
Samprasit W, Chamsai B, Settharaksa S, et al. Synergistic antibacterial activity of alpha mangostin and resveratrol loaded polymer-based films against bacteria infected wound. J Drug Deliv Sci Technol 2020; 57101629
[http://dx.doi.org/10.1016/j.jddst.2020.101629]
[20]
Soni K, Rizwanullah M, Kohli K. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box- Behnken design for improved oral efficacy against cancer: In vitro, ex vivo and in vivo assessments. Artif Cells Nanomed Biotechnol 2018; 46(sup1): 15-31.
[http://dx.doi.org/10.1080/21691401.2017.1408124] [PMID: 29183147]
[21]
Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K. Methods for testing antioxidant activity. Analyst (Lond) 2002; 127(1): 183-98.
[http://dx.doi.org/10.1039/b009171p] [PMID: 11827390]
[22]
Rajurkar NS, Hande SM. Estimation of phytochemical content and antioxidant activity of some selected traditional Indian medicinal plants. Indian J Pharm Sci 2011; 73(2): 146-51.
[http://dx.doi.org/10.4103/0250-474X.91574] [PMID: 22303056]
[23]
Souto EB, Baldim I, Oliveira WP, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Deliv 2020; 17(3): 357-77.
[http://dx.doi.org/10.1080/17425247.2020.1727883] [PMID: 32064958]
[24]
López-García R, Ganem-Rondero A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Occlusive effect and penetration enhancement ability. J Cosmet Dermatol Sci Appl 2015; 05: 62-72.
[http://dx.doi.org/10.4236/jcdsa.2015.52008]
[25]
Kumar S, Lather V, Pandita D. Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma Food Chem 2016; 197(Pt A): 959-64.
[http://dx.doi.org/10.1016/j.foodchem.2015.11.078] [PMID: 26617040]
[26]
Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 2005; 45(3-4): 167-73.
[http://dx.doi.org/10.1016/j.colsurfb.2005.08.005] [PMID: 16198092]
[27]
Singla P, Kanwar R, Sharma R, et al. Proficiency of nanostructured lipid carriers for the formulation of amphiphilic bile acid oligomers. Colloids Surf A Physicochem Eng Asp 2021; 611125841
[http://dx.doi.org/10.1016/j.colsurfa.2020.125841]
[28]
Shaker DS, Ishak RAH, Ghoneim A, et al. Nanoemulsion: A review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Sci Pharm 2019; 87: 17.
[http://dx.doi.org/10.3390/scipharm87030017]
[29]
Ghazali SAISM, Lian GEC, Ghani KDA. Chemical constituent from roots of Garcinia mangostana (Linn.). Int J Chem 2010; 2(1): 134-42.
[http://dx.doi.org/10.5539/ijc.v2n1p134]
[30]
Venuti V, Cannavà C, Cristiano MC, et al. A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity. Colloids Surf B Biointerfaces 2014; 115: 22-8.
[http://dx.doi.org/10.1016/j.colsurfb.2013.11.025] [PMID: 24321846]
[31]
Trivedi KM, Tallapragada RM, Branton A, et al. Physical, spectroscopic and thermal characterization of biofield treated myristic acid. J Fundam Renew Energy Appl 2015; 5: 180.
[http://dx.doi.org/10.4172/20904541.1000180]
[32]
Yang X, Yuan Y, Zhang N, et al. Preparation and properties of myristic–palmitic–stearic acid/expanded graphite composites as phase change materials for energy storage. Sol Energy 2014; 99: 259-66.
[http://dx.doi.org/10.1016/j.solener.2013.11.021]
[33]
Han L, Wang T. Preparation of glycerolmonostearate from glycerol carbonate and stearic acid. RSC Advances 2016; 6: 34137-45.
[http://dx.doi.org/10.1039/C6RA02912D]
[34]
Lira AM, Arajo AAS, Baslio IDJ, et al. Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochim Acta 2007; 457(1–2): 1-6.
[http://dx.doi.org/10.1016/j.tca.2007.02.017]
[35]
Venkatesh GM, Barnett ME, Owusu-Fordjour C, Galop M. Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry. Pharm Res 2001; 18(1): 98-103.
[http://dx.doi.org/10.1023/A:1011087012826] [PMID: 11336360]
[36]
Aisha AFA, Ismail Z, Abu-Salah KM, Majid AM. Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles. J Pharm Sci 2012; 101(2): 815-25.
[http://dx.doi.org/10.1002/jps.22806] [PMID: 22081501]
[37]
Robinson K, Mock C, Liang D. Pre-formulation studies of resveratrol. Drug Dev Ind Pharm 2015; 41(9): 1464-9.
[http://dx.doi.org/10.3109/03639045.2014.958753] [PMID: 25224342]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy